Life Technologies (NASDAQ: LIFE) and the Israeli Office of the Chief Scientist (OCS) in the Ministry of Industry, Trade & Labor have announced plans to cooperate to create partnerships between the company’s Research & Development arm and Israeli industry, in the framework of the OCS' Global Enterprise R&D Collaboration Program.
As part of its business strategy, Life Technologies is actively looking for innovative technologies, products and companies in the biotech, medical devices, Agro-Bio, Synthetic-Bio (production of organic cells out of artificial materials), IT, electronics, optics, and semiconductor industries.
For its part, the OCS will facilitate making the business connections and provide assistance in navigating around regulatory issues and financing if a relationship between an Israeli company and Life Technologies emerges. The OCS policy will be to match Life Technologies investment with up to 50% funding. The agreement was signed by Dr. Alan Sachs, Life Technologies’ Head of Global Science & Innovation, and Mr. Avi Hasson, Chief Scientist of the Ministry of Industry, Trade and Labor of Israel. Twenty-three global corporations have already signed a collaborative agreement and according to the OCS, in recent years the corporate collaboration programs have become an alternative for many corporations to carry out joint projects with innovative Israeli companies.
Life Technologies Corporation is a global biotechnology company with customers in more than 160 countries using its innovative solutions to solve some of today's most difficult scientific challenges. Quality and innovation are accessible to every lab with its reliable and easy-to-use solutions spanning the biological spectrum, with more than 50,000 products for agricultural biotechnology, translational research, molecular medicine and diagnostics, stem cell-based therapies, forensics, food safety and animal health. Its systems, reagents and consumables represent some of the most cited brands in scientific research including: Ion Torrent™, Applied Biosystems®, Invitrogen™, Gibco®, Ambion®, Molecular Probes® and Novex®. Life Technologies employs approximately 10,400 people and upholds its ongoing commitment to innovation with more than 4,000 patents and exclusive licenses. LIFE had sales of $3.7 billion in 2011. Visit us at our website:
Life Technologies has a manufacturing plant in Israel employing around sixty people in Kiryat Shmona. Together with its R&D and Technology Scouting team, the R&D and operations sites in Israel develop and manufacture the E-Gel® and iBlot® product lines, consisting of microchip-controlled electronic-devices and dozens of consumable products. These products are used in bio-medical research and in diagnostic labs worldwide for DNA separation, protein separation and in protein analysis workflows.
The R&D Scouting Team, headed by Dr. Ari Gargir, is looking for Israeli technologies and companies who are interested in creating business connections with the global corporate of Life Technologies, and is being a local contact point for proposals for such cooperation.
Please contact Ari.Gargir@lifetech.com.